McKesson Corporation Overview
Industry: Medical Distribution
Sector: Healthcare
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, s Read MoreMavefund brings filings, fundamentals, valuation, price history and news for McKesson Corporation into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $96.3B (+6% YoY); EPS was $13.71 (reported).
Revenue
$96.3B
+6% YoY
EPS
$13.71
reported
Operating income
$1.2B
reported
Net loss
-$667M
reported
What changed
- Revenue +6% YoY to $96.3B; EPS reported to $13.71.
- Capital return update: free cash flow $5.4B.
- Net income +42% YoY to $1.9B.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
McKesson (MCK) Declares Quarterly Dividend, Is The Stock Still Undervalued?
Headline from Yahoo Finance: McKesson (MCK) Declares Quarterly Dividend, Is The Stock Still Undervalued?
Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK)
Headline from Yahoo Finance: Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK).
McKesson raises quarterly dividend 15% to $0.94 per share
Headline from Investing.com: McKesson raises quarterly dividend 15% to $0.94 per share.
McKesson raises quarterly dividend 15% to $0.94 per share By Investing.com
Headline from Investing.com UK: McKesson raises quarterly dividend 15% to $0.94 per share By Investing.com.
McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share
Headline from Business Wire: McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share.
McKesson (MCK) Q4 2026 Earnings Call Transcript
Headline from Fortune: McKesson (MCK) Q4 2026 Earnings Call Transcript.
Earnings Per Share
Score 3.00/5
McKesson Corporation boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Medical Distribution industry
, Patterson Companies Inc
, Zynex Inc
, Cardinal Health Inc
are companies with high ratings.
Return on Equity
Score 0.36/5
McKesson Corporation exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 4.39/5
McKesson Corporation
commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 1.26/5
McKesson Corporation
registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
have achieved high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios